Larvol Delta - Adicet-Bio-Announces-First-Patient-Dosed-in-Phase-1-Clinical-Trial-of-ADI001-in-TreatmentRefractory-Rheumatoid-Arthritis-RA

ADI-001 - Adicet Bio

https://www.businesswire.com/news/home/20251016177401/en/Adicet-Bio-Announces-First-Patient-Dosed-in-Phase-1-Clinical-Trial-of-ADI-001-in-Treatment-Refractory-Rheumatoid-Arthritis-RA

Oct 16, 2025

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next